bf/NASDAQ:AXSM_icon.jpeg

COM:AXSOME

Axsome Therapeutics

  • Stock

USD

Last Close

98.19

22/11 21:00

Market Cap

3.92B

Beta: -

Volume Today

425.39K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-2.17M
-
-6.00M
176.95%
-10.56M
75.98%
-27.20M
157.60%
-28.94M
6.40%
-30.97M
6.99%
-68.35M
120.71%
-102.90M
50.56%
-130.40M
26.73%
-187.13M
43.50%
-239.24M
27.84%
depreciation and amortization
3.54K
-
20.48K
478.32%
42.56K
107.76%
48.94K
14.99%
37.33K
23.72%
77.72K
108.19%
1.16M
1,387.00%
5.56M
381.47%
6.83M
22.82%
deferred income tax
2.28M
-
646K
-
-2.79M
532.04%
1.25M
-
63.20M
-
stock based compensation
55.28K
-
376.81K
581.62%
803.28K
113.18%
2.03M
152.89%
2.07M
2.01%
1.75M
15.31%
6.12M
248.45%
14.76M
141.31%
20.80M
40.97%
37.73M
81.36%
62.62M
65.99%
change in working capital
153.09K
-
514.69K
236.20%
937.73K
82.19%
3.80M
305.18%
-759.55K
119.99%
1.52M
300.54%
15.17M
895.76%
412.04K
97.28%
324.79K
21.18%
23.67M
7,187.56%
-28.39M
219.95%
accounts receivables
177.50K
-
5.54K
96.88%
-37.70M
681,199.69%
-57.12M
51.52%
inventory
-177.50K
-
-5.54K
96.88%
-5.28M
95,204.64%
-8.16M
54.61%
accounts payables
158.14K
-
598.84K
278.68%
1.13M
89.40%
2.19M
92.98%
-645.72K
129.50%
251.79K
138.99%
7.26M
2,781.81%
2.56M
64.71%
-354.69K
113.85%
25.46M
7,276.91%
2.07M
91.85%
other working capital
-5.05K
-
-84.14K
1,567.23%
-196.48K
133.50%
1.61M
919.79%
-113.83K
107.07%
1.27M
1,216.95%
7.91M
522.26%
-2.15M
127.16%
679.48K
131.62%
41.19M
5,961.56%
34.81M
15.48%
other non cash items
327.19K
-
512.67K
56.69%
-902.22K
275.98%
68.93K
107.64%
470.52K
582.61%
375.63K
20.17%
649.99K
73.04%
7.95M
1,123.25%
-104.61K
101.32%
3.66M
3,602.00%
-10.11M
375.90%
net cash provided by operating activities
-1.63M
-
-4.60M
181.80%
-7.44M
61.84%
-21.28M
186.08%
-26.47M
24.39%
-30.05M
13.53%
-46.38M
54.31%
-78.46M
69.18%
-108.23M
37.94%
-116.51M
7.66%
-145.08M
24.52%
investments in property plant and equipment
-20.20K
-
-104.56K
417.76%
-9.90K
90.53%
-32.70K
230.33%
-16.12K
50.69%
-45.89K
184.67%
-307.55K
570.17%
-702.11K
128.29%
-582K
17.11%
acquisitions net
-53M
-
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-20.20K
-
-104.56K
417.76%
-9.90K
90.53%
-32.70K
230.33%
-16.12K
50.69%
-45.89K
184.67%
-307.55K
570.17%
-53.70M
17,361.32%
-582K
98.92%
debt repayment
-21K
-
-41.47K
97.47%
-277.78K
-
-3.33M
1,100.00%
-7.24M
117.17%
-21.66M
199.22%
-44.51M
-
-83.56M
87.72%
common stock issued
45.55M
-
23.68M
-
12.88M
45.60%
238.23M
1,749.45%
14.13M
94.07%
7.21M
48.94%
236.79M
3,183.08%
255.50M
7.90%
common stock repurchased
-175.71K
-
-531.83K
202.67%
dividends paid
-43.98M
-
other financing activites
3.72M
-
5.15M
38.47%
7.37M
43.18%
9.97M
35.25%
484.61K
95.14%
486.03K
0.29%
21.39M
4,301.74%
49.95M
133.47%
4.09M
91.81%
136.82M
3,242.72%
159.07M
16.26%
net cash used provided by financing activities
3.72M
-
5.13M
37.91%
52.88M
931.48%
9.97M
81.15%
23.88M
139.61%
10.03M
57.99%
252.39M
2,415.33%
42.41M
83.20%
11.13M
73.76%
284.58M
2,456.96%
331.01M
16.32%
effect of forex changes on cash
45
-
net change in cash
2.09M
-
529.97K
74.60%
45.42M
8,469.97%
-11.42M
125.14%
-2.60M
77.25%
-20.05M
672.03%
206.00M
1,127.30%
-36.09M
117.52%
-97.40M
169.89%
114.37M
217.42%
185.35M
62.06%
cash at beginning of period
1.63K
-
2.09M
128,303.63%
2.62M
25.38%
48.04M
1,734.98%
36.62M
23.77%
34.02M
7.09%
13.97M
58.94%
219.97M
1,474.70%
183.88M
16.41%
86.47M
52.97%
200.84M
132.26%
cash at end of period
2.09M
-
2.62M
25.38%
48.04M
1,734.98%
36.62M
23.77%
34.02M
7.09%
13.97M
58.94%
219.97M
1,474.70%
183.88M
16.41%
86.47M
52.97%
200.84M
132.26%
386.19M
92.29%
operating cash flow
-1.63M
-
-4.60M
181.80%
-7.44M
61.84%
-21.28M
186.08%
-26.47M
24.39%
-30.05M
13.53%
-46.38M
54.31%
-78.46M
69.18%
-108.23M
37.94%
-116.51M
7.66%
-145.08M
24.52%
capital expenditure
-20.20K
-
-104.56K
417.76%
-9.90K
90.53%
-32.70K
230.33%
-16.12K
50.69%
-45.89K
184.67%
-307.55K
570.17%
-702.11K
128.29%
-582K
17.11%
free cash flow
-1.63M
-
-4.60M
181.80%
-7.46M
62.28%
-21.39M
186.71%
-26.48M
23.83%
-30.09M
13.61%
-46.39M
54.19%
-78.50M
69.22%
-108.53M
38.25%
-117.21M
8.00%
-145.66M
24.27%

All numbers in USD (except ratios and percentages)